Literature DB >> 25480698

Proposing the use of dental pulp stem cells as a suitable biological model of neurofibromatosis type 1.

Paula Nascimento Almeida1, Gustavo Torres Souza, Camila Maurmann de Souza, Rafaella Souza Salomão de Zanette, Claudinéia Pereira Maranduba, João Vitor Paes Rettore, Marcelo Oliveira de Santos, Antônio Márcio Resende do Carmo, Carlos Magno Costa da Maranduba, Fernando Sá de Silva.   

Abstract

PURPOSE: This study aims to propose the dental pulp stem cells (DPSCs) as a model for studying two features related to neurofibromatosis type 1 (NF1), i.e. augmented proliferative capacity and altered osteogenic differentiation.
METHODS: We isolated a DPSC from the pulp of deciduous teeth of a 6-year-old NF1 patient and two other healthy children of similar age. Cell proliferation was assayed by counting with a haemocytometer after successive cell re-plating. In order to compare osteogenic differentiation, we used osteoblast-differentiating medium and quantified alizarin stain, which relates to degree of calcification, and evaluated the expression of osteoblastic markers by reverse transcription polymerase chain reaction (RT-PCR).
RESULTS: The DPSCs isolated from the NF1 patient displayed a greater rate of proliferation when compared to the control cells. Osteogenic differentiation occurred as expected for both NF1 and control, which concerned cell morphology and expression of osteoblast marker genes ALP, BMP2, BMP4, OCN and SPP1. However, alizarin staining denoted a markedly lower calcification level in the cells from the NF1-diagnosed child, considering that less calcium deposits were visualized under light microscopy and a smaller amount of alizarin could be quantified by spectrophotometry after extraction from the stained cells.
CONCLUSION: DPSCs seem to be useful as a model for studying NF1 and predicting prognosis of patients, since their in vitro behaviour seems to mimic at least two features of this disorder: higher tendency to develop bone abnormalities and neoplastic cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25480698     DOI: 10.1007/s00381-014-2599-9

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  21 in total

1.  Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo.

Authors:  S Gronthos; M Mankani; J Brahim; P G Robey; S Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Osteogenic differentiation of human dental pulp-derived stem cells under various ex-vivo culture conditions.

Authors:  Jana Karbanová; Tomás Soukup; Jakub Suchánek; Jaroslav Mokrý
Journal:  Acta Medica (Hradec Kralove)       Date:  2010

3.  Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I.

Authors:  Weixi Wang; Jeffry S Nyman; Koichiro Ono; David A Stevenson; Xiangli Yang; Florent Elefteriou
Journal:  Hum Mol Genet       Date:  2011-07-14       Impact factor: 6.150

4.  The handwriting performance of children with NF1.

Authors:  Yafit Gilboa; Naomi Josman; Aviva Fattal-Valevski; Hagit Toledano-Alhadef; Sara Rosenblum
Journal:  Res Dev Disabil       Date:  2010-04-14

5.  Therapeutics for childhood neurofibromatosis type 1 and type 2.

Authors:  Simone L Ardern-Holmes; Kathryn N North
Journal:  Curr Treat Options Neurol       Date:  2011-12       Impact factor: 3.598

Review 6.  Modeling cognitive dysfunction in neurofibromatosis-1.

Authors:  Kelly A Diggs-Andrews; David H Gutmann
Journal:  Trends Neurosci       Date:  2013-01-08       Impact factor: 13.837

7.  Neurofibromatosis type 1 and autism spectrum disorder.

Authors:  Shruti Garg; Jonathan Green; Kathy Leadbitter; Richard Emsley; Annukka Lehtonen; D Gareth Evans; Susan M Huson
Journal:  Pediatrics       Date:  2013-11-04       Impact factor: 7.124

8.  Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression.

Authors:  Hannu-Ville Leskelä; Tommi Kuorilehto; Juha Risteli; Jussi Koivunen; Marja Nissinen; Sirkku Peltonen; Pentti Kinnunen; Ludwine Messiaen; Petri Lehenkari; Juha Peltonen
Journal:  Bone       Date:  2008-11-12       Impact factor: 4.398

9.  Underlying mechanisms of writing difficulties among children with neurofibromatosis type 1.

Authors:  Yafit Gilboa; Naomi Josman; Aviva Fattal-Valevski; Hagit Toledano-Alhadef; Sara Rosenblum
Journal:  Res Dev Disabil       Date:  2014-03-30

Review 10.  Neurofibromatosis type 1 revisited.

Authors:  Virginia C Williams; John Lucas; Michael A Babcock; David H Gutmann; Bruce Korf; Bernard L Maria
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

View more
  3 in total

1.  Effects of resveratrol on the proliferation and osteogenic differentiation of deciduous dental pulp stem cells from neurofibromatosis type 1 patient.

Authors:  Claudinéia Pereira Maranduba; Gustavo Torres Souza; Antônio Márcio Resende do Carmo; José Marcelo Sallabert de Campos; Nádia Rezende Barbosa Raposo; Marcelo de Olivera Santos; Carlos Magno da Costa Maranduba; Fernando de Sá Silva
Journal:  Childs Nerv Syst       Date:  2020-11-20       Impact factor: 1.475

2.  Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.

Authors:  Paula Nascimento Almeida; Deuilton do Nascimento Barboza; Eloá Borges Luna; Maria Clara de Macena Correia; Rhayra Braga Dias; Ana Caroline Siquara de Sousa; Maria Eugenia Leite Duarte; Maria Isabel Doria Rossi; Karin Soares Cunha
Journal:  Orphanet J Rare Dis       Date:  2018-06-25       Impact factor: 4.123

Review 3.  Mechanisms underlying dental-derived stem cell-mediated neurorestoration in neurodegenerative disorders.

Authors:  Syed Shadab Raza; Aurel Popa Wagner; Yawer S Hussain; Mohsin Ali Khan
Journal:  Stem Cell Res Ther       Date:  2018-09-26       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.